drugset
drugset / Trial / NCT01941056

Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus

NCT01941056 ↗

Phase 1 Completed 24 enrolled City of Hope Medical Center National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelSupportive care

Summary

This phase I trial studies the side effects and the best dose of vaccine therapy in healthy volunteers with or without previous exposure to cytomegalovirus. Vaccines made from a gene-modified virus may help the body build an immune response and may help prevent cytomegalovirus infection.

Timeline

Start
2014-01-05
Primary completion
2017-07-28
Completion
2017-07-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Multi-peptide CMV-Modified Vaccinia Ankara Vaccine Vaccine — Intramuscular

Indications

cytomegalovirus infection